Why Utah Medical Products, Inc.’s (UTMD) Stock Is Down 5.69%
As of Thursday, July 23, Utah Medical Products, Inc.’s UTMD share price has dipped by 5.69%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Stock Evaluator: Utah Medical Products, Inc. (UTMD)
Utah Medical Products, Inc. UTMD
$70.52
0.95
1.37%
July 31, 2026 4:00:00 PM
EST
Volume: 22,531
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women’s health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Commentary & Analysis
Why Utah Medical Products, Inc.’s (UTMD) Stock Is Up 6.61%
As of Friday, June 26, Utah Medical Products, Inc.’s UTMD share price has surged by 6.61%, which has investors questioning if this is right time to sell.Rosalio Madrigal
6 Undervalued Health Care Equipment & Supplies Stocks for Friday, May 08
Discover the top 6 undervalued Health Care Equipment & Supplies stocks for Friday, May 08 based on AAII’s Stock Grades.Michael Rose
3 Undervalued Health Care Equipment & Supplies Stocks for Friday, February 06
Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Friday, February 06 based on AAII’s Stock Grades.Tudor Pop
3 Undervalued Health Care Equipment & Supplies Stocks for Friday, October 10
Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Friday, October 10 based on AAII’s Stock Grades.Omar Beirat
Financial Summary
| Share Statistics | UTMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $224.5 | $337.2 | 29% |
|
| Shares Out (Mil) | 3.2 | 41.9 | 10% |
|
| Institutional Ownership | 90.5% | 77.8% | 59% |
|
| Float (Mil) | 2.8 | 34.7 | 7% |
|
| Beta | 0.36 | 0.85 | 20% |
|
| Avg Daily Volume (000s) | 44 | 278 | 27% |
|
| Price Change (52-week) |
25.1% | 58.7% | 65% |
|
| Growth | UTMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (1.8%) | 11.8% | 13% |
|
| Net Income (5yr) | 0.9% | (5.8%) | 41% |
|
| EPS (5yr) | 3.4% | 11.4% | 36 |
|
| Dividends (5yr) | 1.8% | 0.0% | 82% |
|
| Cash Flow (5yr) | (18.6%) | (16.3%) | 36% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | UTMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $38 | $152 | 18% |
|
| Net Income (TTM) (Mil) | $11 | ($10) | 46% |
|
| EPS (TTM) | $3.381 | ($0.500) | 81% |
|
| Operating Cash Flow (TTM) (Mil) | $13 | ($2) | 39% |
|
| Net Cash Flow (TTM) (Mil) | $4 | $1 | 52% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $22 | 12% |
|
| Enterprise Value (Q1) (Mil) | $110 | $304 | 22% |
|
| Valuation | UTMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.87 | 2.80 | 49% |
|
| P/E | 20.9 | 31.1 | 53% |
|
| Dividend Yield | 1.8% | 0.0% | 74% |
|
| PEG (5yr hist) | 6.1 | 1.9 | 89% |
|
| Ratios | UTMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 57.9% | 59.1% | 70% |
|
| Net Margin | 29.0% | (7.3%) | 88% |
|
| ROA | 8.8% | (13.7%) | 85% |
|
| ROE | 9.1% | (15.8%) | 55% |
|
| Liabilities to Assets | 3.2% | 44.7% | 1% |
|
| F-Score | 6 | 4 | 69% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Cash Rich Firms Screen
Factors: Value, Quality
Locating firms with a high proportion of cash to share price.
| Performance Since Inception: | 6.5% |
| +/- S&P 500: | -1.0 |
